Differences Between Pediatric and Adult Protocols and Medical Centers in the Treatment of Acute Myeloid Leukemia in the United States

J Adolesc Young Adult Oncol. 2023 Apr;12(2):147-150. doi: 10.1089/jayao.2021.0231. Epub 2022 Jul 13.

Authors

John S Underwood¹, Nematullah Sharaf², Andrew R W O'Brien¹, Sandeep Batra³, Heiko Konig¹, Jodi L Skiles³

Affiliations

¹ Department of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
² Internal Medicine/Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
³ Pediatric Hematology/Oncology, Riley Hospital for Children at Indiana University School of Medicine, Indianapolis, Indiana, USA.

PMID: 35834614
DOI: 10.1089/jayao.2021.0231

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols
Child
Hospitals
Humans
Leukemia, Myeloid, Acute* / therapy
Prognosis
United States / epidemiology